STAASTAAR SURGICAL CO

Nasdaq staar.com


$ 42.90 $ 1.84 (4.49 %)    

Thursday, 09-May-2024 15:59:56 EDT
QQQ $ 442.44 $ -0.48 (-0.11 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 521.52 $ 0.00 (0 %)
TLT $ 90.31 $ 0.00 (0 %)
GLD $ 218.88 $ -0.90 (-0.41 %)
$ 42.86
$ 41.62
$ 0.00 x 0
$ 0.00 x 0
$ 41.48 - $ 43.26
$ 26.66 - $ 68.27
809,384
na
2.1B
$ 1.25
$ 137.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-29-2024 10-Q
2 02-27-2024 12-29-2023 10-K
3 11-06-2023 09-29-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-23-2023 12-30-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-10-2022 07-01-2022 10-Q
9 05-04-2022 04-01-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-03-2021 10-01-2021 10-Q
12 08-04-2021 07-02-2021 10-Q
13 05-05-2021 04-02-2021 10-Q
14 02-24-2021 01-01-2021 10-K
15 11-04-2020 10-02-2020 10-Q
16 08-05-2020 07-03-2020 10-Q
17 05-06-2020 04-03-2020 10-Q
18 02-26-2020 01-03-2020 10-K
19 10-30-2019 09-27-2019 10-Q
20 07-31-2019 06-28-2019 10-Q
21 05-01-2019 03-29-2019 10-Q
22 02-21-2019 12-28-2018 10-K
23 10-31-2018 09-28-2018 10-Q
24 08-01-2018 06-29-2018 10-Q
25 05-02-2018 03-30-2018 10-Q
26 02-28-2018 12-29-2017 10-K
27 11-08-2017 09-29-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 03-02-2017 12-30-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-03-2016 07-01-2016 10-Q
33 05-11-2016 04-01-2016 10-Q
34 03-11-2016 01-01-2016 10-K
35 11-04-2015 10-02-2015 10-Q
36 08-07-2015 07-03-2015 10-Q
37 05-12-2015 04-03-2015 10-Q
38 03-13-2015 01-02-2015 10-K
39 11-07-2014 10-03-2014 10-Q
40 07-31-2014 07-04-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-staar-surgical

Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.

 canaccord-genuity-maintains-hold-on-staar-surgical-lowers-price-target-to-43

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 ...

 piper-sandler-maintains-neutral-on-staar-surgical-raises-price-target-to-40

Piper Sandler analyst Matt O'Brien maintains Staar Surgical (NASDAQ:STAA) with a Neutral and raises the price target fro...

 mizuho-maintains-buy-on-staar-surgical-raises-price-target-to-55

Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $53 to $55.

 staar-surgical-announces-strategic-agreement-with-iq-laser-vision-in-us

Agreement is Largest Commitment to EVO ICL™ in the U.S.STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer ...

 staar-surgical-q1-2024-gaap-eps-007-beats-011-estimate

Staar Surgical (NASDAQ:STAA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11...

 apple-to-210-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 mizuho-maintains-buy-on-staar-surgical-raises-price-target-to-53

Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $45 to $53.

 canaccord-genuity-maintains-hold-on-staar-surgical-raises-price-target-to-46

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and raises the price target from $32 ...

 eye-lens-maker-staar-surgical-expects-q1-sales-to-beat-consensus

STAAR Surgical reports Q1 2024 net sales surpassing $77 million, with U.S. ICL sales hitting $5 million, the highest since FDA ...

 why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

 needham-reiterates-hold-on-staar-surgical

Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.

Core News & Articles
Market-Moving News for April 4th
04/04/2024 12:33:04

TVGN: 101% | Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development CADL: 62% | Candel Ther...

 staar-surgical-reports-preliminary-net-sales-for-q1-to-be-in-excess-of-77m-est-72134m-now-expects-fy24-net-sales-can-be-at-higher-end-of-prior-outlook-range-of-335m-340m-est-337208m

U.S. ICL sales expected to be $5 million for the quarter. This represents the Company's highest quarterly ICL sales in the ...

 stifel-maintains-buy-on-staar-surgical-maintains-50-price-target

Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Buy and maintains $50 price target.

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 netflix-to-rally-around-20-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION